Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan 11;64(Pt 2):o435.
doi: 10.1107/S1600536808000111.

1-Methyl-2-(4-methyl-phen-yl)-4-morpholinopyridazine-3,6(1H,2H)-dione

1-Methyl-2-(4-methyl-phen-yl)-4-morpholinopyridazine-3,6(1H,2H)-dione

Andrzej Gzella et al. Acta Crystallogr Sect E Struct Rep Online. .

Abstract

The structure analysis of the title compound, C(16)H(19)N(3)O(3), has been undertaken in order to facilitate the inter-pretation of (1)H and (13)C NMR data and to determine the position of the morpholine residue in this nucleophilic substitution product. The main result is that the morpholine group, with a chair conformation, is connected at the 4-position of the pyridazine ring. The benzene and pyridazine rings make a dihedral angle of 62.17 (5)°. Mol-ecules are linked into a two-dimensional network by non-classical C-H⋯O hydrogen bonds, in which O atoms serve as double or triple acceptors.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The molecular structure of (I), showing the atomic labelling scheme. Non-H atoms are drawn as 30% probability displacement ellipsoids.
Fig. 2.
Fig. 2.
Molecular packing and hydrogen bonds (dotted lines); symmetry codes: (i) 1 - x, 1/2 + y, 1 - z, (ii) 2 - x, 1/2 + y, -z. H atoms not involved in hydrogen bonds have been omitted for clarity.
Fig. 3.
Fig. 3.
Molecular packing and hydrogen bonds (dotted lines); symmetry codes: (i) 1 - x, 1/2 + y, 1 - z, (ii) 2 - x, 1/2 + y, -z. H atoms not involved in hydrogen bonds have been omitted for clarity.

References

    1. Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1–19.
    1. Bałoniak, S. & Melzer, E. (1979). Acta Pol. Pharm.36, 147–154.
    1. Farrugia, L. J. (1997). J. Appl. Cryst.30, 565.
    1. Farrugia, L. J. (1999). J. Appl. Cryst.32, 837–838.
    1. Flack, H. D. (1983). Acta Cryst. A39, 876–881.